Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
SAMDAILY.US - ISSUE OF AUGUST 18, 2021 SAM #7200
SOLICITATION NOTICE

66 -- Cell Analysis System

Notice Date
8/16/2021 9:06:03 AM
 
Notice Type
Presolicitation
 
NAICS
325412 — Pharmaceutical Preparation Manufacturing
 
Contracting Office
NATIONAL INSTITUTES OF HEALTH - CC BETHESDA MD 20892 USA
 
ZIP Code
20892
 
Solicitation Number
21-010816
 
Response Due
8/23/2021 8:00:00 AM
 
Archive Date
08/24/2021
 
Point of Contact
Priscilla Abalos, Phone: 3015945918
 
E-Mail Address
prisclla.abalos@nih.gov
(prisclla.abalos@nih.gov)
 
Small Business Set-Aside
SBP Partial Small Business Set-Aside (FAR 19.5)
 
Description
Solicitation # HHSNIHOPCSBSS-21-010816 Date Posted ����8-16-2021 Date Closed���� 8-23-21 This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institute of Health (NIH), Clinical Center (CC),Critical Care Medicine Department (CCMD) intends to solicit a quote and enter into firm-fixed price for Cell analysis System, with Becton and Dickenson The Center for Cellular Engineering (CCE)� is responsible for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy and gene therapy conducted in the Clinical Center at the NIH. Cell processing procedures are tailored to each of the 30 or more different patient-care clinical research protocols supported The BD Rhapsody Express Single-Cell Analysis System will be used for Dr. Panch�s research project to characterize CAR-T cells and other engineered cells products at single cell level. The purpose of this correspondence is to request a PO to purchase a �instrument tol be used for clinical research, the nature of harm would be that CCE/DTM would be unable to provide accurate genes and antibody detection results at single cell level for clinical research, which could be to the detriment of the patient in the future.��� This acquisition is being conducted using policies unique to the acquisition of commercial items prescribed in FAR Part 12, in conjunction with the policies and procedures for the competition requirements of Part 6. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date, AUGUST 23, 2021 at 11:00 EST specified in this announcement, electronically to the attention of Priscilla Abalos, Contract Specialist, Priscilla.abalos@nih.gov by the due date and time marked in this notice.
 
Web Link
SAM.gov Permalink
(https://beta.sam.gov/opp/f153bc905d9a46f2b3f6ae7fef07d62e/view)
 
Place of Performance
Address: Bethesda, MD, USA
Country: USA
 
Record
SN06098642-F 20210818/210816230119 (samdaily.us)
 
Source
SAM.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.